Login
Home
Charts
Search
Watchlist
Products

Hemadri Cements Ltd

HEMACEM·BSE
50.880.00%Fri, 21 Nov '25

Hemadri Cements Ltd

HEMACEM
BSE
50.88
0.00%
|Fri, 21 Nov '25
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
34Cr
Close
Close Price
50.88
Industry
Industry
Cement
PE
Price To Earnings
PS
Price To Sales
Revenue
Revenue
0Cr
Rev Gr TTM
Revenue Growth TTM
-100.00%
PAT Gr TTM
PAT Growth TTM
85.61%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
121514710000000
Growth YoY
Revenue Growth YoY%
0.3-18.7-25.1-54.9-88.2-100.0-100.0-100.0-100.0
Expenses
ExpensesCr
1515181643421321
Operating Profit
Operating ProfitCr
-30-4-10-2-3-4-2-1-3-2-1
OPM
OPM%
-25.82.7-25.8-150.5-173.9
Other Income
Other IncomeCr
000000000080
Interest Expense
Interest ExpenseCr
000000100000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
-30-4-10-3-3-5-3-2-37-1
Tax
TaxCr
00-2000600040
PAT
PATCr
-40-3-10-3-3-11-3-2-33-1
Growth YoY
PAT Growth YoY%
25.989.834.6-128.619.7-731.6-325.972.435.61.6125.379.1
NPM
NPM%
-29.1-2.5-17.5-159.3-197.9
EPS
EPS
-5.3-0.6-3.8-15.6-4.2-4.7-16.0-4.3-2.7-4.74.1-0.9
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
121514710000000
Growth YoY
Revenue Growth YoY%
0.3-18.7-25.1-54.9-88.2-100.0-100.0-100.0-100.0
Expenses
ExpensesCr
1515181643421321
Operating Profit
Operating ProfitCr
-30-4-10-2-3-4-2-1-3-2-1
OPM
OPM%
-25.82.7-25.8-150.5-173.9
Other Income
Other IncomeCr
000000000080
Interest Expense
Interest ExpenseCr
000000100000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
-30-4-10-3-3-5-3-2-37-1
Tax
TaxCr
00-2000600040
PAT
PATCr
-40-3-10-3-3-11-3-2-33-1
Growth YoY
PAT Growth YoY%
25.989.834.6-128.619.7-731.6-325.972.435.61.6125.379.1
NPM
NPM%
-29.1-2.5-17.5-159.3-197.9
EPS
EPS
-5.3-0.6-3.8-15.6-4.2-4.7-16.0-4.3-2.7-4.74.1-0.9

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
928582757095826856800
Growth
Revenue Growth%
8.9-7.2-3.7-8.3-7.036.2-13.6-17.1-18.3-85.8-100.0-100.0
Expenses
ExpensesCr
8177817768908188662787
Operating Profit
Operating ProfitCr
1181-2261-20-11-19-8-7
OPM
OPM%
11.79.31.6-2.62.65.81.3-29.4-18.9-243.6
Other Income
Other IncomeCr
111400221199
Interest Expense
Interest ExpenseCr
000110011110
Depreciation
DepreciationCr
111112222211
PBT
PBTCr
11811040-20-13-21-11
Tax
TaxCr
4700030-5-2604
PAT
PATCr
7101010-15-11-27-1-3
Growth
PAT Growth%
-4.5-83.3-55.1110.9-86.6771.9-64.7-3,698.228.5-147.595.385.6
NPM
NPM%
7.11.30.61.40.21.30.5-22.4-19.6-340.5
EPS
EPS
9.81.60.71.50.21.80.6-22.9-16.4-40.6-7.6-4.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
928582757095826856800
Growth
Revenue Growth%
8.9-7.2-3.7-8.3-7.036.2-13.6-17.1-18.3-85.8-100.0-100.0
Expenses
ExpensesCr
8177817768908188662787
Operating Profit
Operating ProfitCr
1181-2261-20-11-19-8-7
OPM
OPM%
11.79.31.6-2.62.65.81.3-29.4-18.9-243.6
Other Income
Other IncomeCr
111400221199
Interest Expense
Interest ExpenseCr
000110011110
Depreciation
DepreciationCr
111112222211
PBT
PBTCr
11811040-20-13-21-11
Tax
TaxCr
4700030-5-2604
PAT
PATCr
7101010-15-11-27-1-3
Growth
PAT Growth%
-4.5-83.3-55.1110.9-86.6771.9-64.7-3,698.228.5-147.595.385.6
NPM
NPM%
7.11.30.61.40.21.30.5-22.4-19.6-340.5
EPS
EPS
9.81.60.71.50.21.80.6-22.9-16.4-40.6-7.6-4.2

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
77777777777
Reserves
ReservesCr
394040414142432816-1022
Current Liabilities
Current LiabilitiesCr
15141518161621202277
Non Current Liabilities
Non Current LiabilitiesCr
111002222210
Total Liabilities
Total LiabilitiesCr
6262636664677256482435
Current Assets
Current AssetsCr
3130302625344027261135
Non Current Assets
Non Current AssetsCr
313232404033322922140
Total Assets
Total AssetsCr
6262636664677256482435
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
77777777777
Reserves
ReservesCr
394040414142432816-1022
Current Liabilities
Current LiabilitiesCr
15141518161621202277
Non Current Liabilities
Non Current LiabilitiesCr
111002222210
Total Liabilities
Total LiabilitiesCr
6262636664677256482435
Current Assets
Current AssetsCr
3130302625344027261135
Non Current Assets
Non Current AssetsCr
313232404033322922140
Total Assets
Total AssetsCr
6262636664677256482435

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
16-1-4212-5-112-7-20
Investing Cash Flow
Investing Cash FlowCr
-1-30-900-100041
Financing Cash Flow
Financing Cash FlowCr
0006-2-656-28-21
Net Cash Flow
Net Cash FlowCr
03-1-706-1-6011
Free Cash Flow
Free Cash FlowCr
02-2-13112-6-121-721
CFO To PAT
CFO To PAT%
18.8548.3-175.7-342.21,213.01,012.9-1,264.874.5-14.725.61,540.4
CFO To EBITDA
CFO To EBITDA%
11.374.9-63.9176.890.1219.5-505.156.8-15.335.7230.1
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
16-1-4212-5-112-7-20
Investing Cash Flow
Investing Cash FlowCr
-1-30-900-100041
Financing Cash Flow
Financing Cash FlowCr
0006-2-656-28-21
Net Cash Flow
Net Cash FlowCr
03-1-706-1-6011
Free Cash Flow
Free Cash FlowCr
02-2-13112-6-121-721
CFO To PAT
CFO To PAT%
18.8548.3-175.7-342.21,213.01,012.9-1,264.874.5-14.725.61,540.4
CFO To EBITDA
CFO To EBITDA%
11.374.9-63.9176.890.1219.5-505.156.8-15.335.7230.1

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
614434
Price To Earnings
Price To Earnings
Price To Sales
Price To Sales
1.15.6
Price To Book
Price To Book
2.6-11.6-3.8
EV To EBITDA
EV To EBITDA
-6.8-3.3-9.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
26.323.320.620.229.335.026.75.418.7-30.6
OPM
OPM%
11.79.31.6-2.62.65.81.3-29.4-18.9-243.6
NPM
NPM%
7.11.30.61.40.21.30.5-22.4-19.6-340.5
ROCE
ROCE%
23.516.92.02.52.38.11.2-43.0-33.2-117.8-2.0-2.0
ROE
ROE%
14.42.41.02.10.32.50.9-44.7-47.5711.3-4.5-4.5
ROA
ROA%
10.61.80.81.60.21.80.6-27.2-22.9-111.1-3.6-3.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
614434
Price To Earnings
Price To Earnings
Price To Sales
Price To Sales
1.15.6
Price To Book
Price To Book
2.6-11.6-3.8
EV To EBITDA
EV To EBITDA
-6.8-3.3-9.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
26.323.320.620.229.335.026.75.418.7-30.6
OPM
OPM%
11.79.31.6-2.62.65.81.3-29.4-18.9-243.6
NPM
NPM%
7.11.30.61.40.21.30.5-22.4-19.6-340.5
ROCE
ROCE%
23.516.92.02.52.38.11.2-43.0-33.2-117.8-2.0-2.0
ROE
ROE%
14.42.41.02.10.32.50.9-44.7-47.5711.3-4.5-4.5
ROA
ROA%
10.61.80.81.60.21.80.6-27.2-22.9-111.1-3.6-3.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Hemadri Cements Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/aggwq7eczlzzxz09v5dpp2q3.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/xwn3f38hkxj0vza3y3n31jlo.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/3rsvqf2tqz0c0n9nywxjx9rn.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/qxbxd2o546w3bfvk1iwb1wb4.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/yaxf35ai54eivkduq2fgdbt1.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/z8es8e7q7cavlnoma5mnqoh4.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/mdubr0ztc0n3froew8faft9p.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/qcgv8q1r4nn7f14qjxcap08y.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/wgltq3ugebh0tq88emzeb11x.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/3ejhhvhdzz5ewjevhwh4eeyw.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/qccwyhfg6akm1neao4mt9h5f.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/y5n0llpdulbu5pnb5y0vquoj.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/dh4ttk0b0n06wwo7cvshpap1.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/wcficcgzertcul8ab9qemxve.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/5l0i8ffww4593aku3vm8ir1l.pdf